臨床研究等提出・公開システム

Development of a telemedicine system for dementia - An exploratory study of the usefulness of Carebee, a telecommunication tool for people with dementia.

Carebee Study

15

All patients were in their 70s or older; three were male and 12 were female; one patient in her 90s participated in the study. MMSE scores within 6 months of study participation ranged from 13 to 28. The primary caregivers were 6 husbands, 3 wives, 4 daughters, and 2 other relatives. Ten participants were diagnosed with Alzheimer's disease, three with dementia with Lewy bodies or suspected Lewy body dementia, and two with suspected tauopathy in the elderly.

Of the 15 participants, 14 were able to complete up to Step 2, and only one participant was able to complete up to Step 1. Dropout was due to family reasons, being away from home at the time of the final evaluation, and was not study-induced dropout.

No adverse events occurred.

Regarding the primary endpoint, the rate of continued use of the system (usefulness was defined as 11 or more cases continued to use the system after 4 weeks), all 15 cases were judged to be useful with a checklist score of 4 or higher for Stage A. The primary endpoint was the rate of continued use of the system (usefulness was defined as 11 or more cases continued to use the system after 4 weeks). The rate of continued use of the system after 8 weeks, which was set as a secondary endpoint, was 14/15 (93.3%), showing a high rate of continued use, similar to that after 4 weeks. Both the 4-week and 8-week continuation use rates cleared 11 of 15 patients (73.3%), with 100% (p<0.01) at 4 weeks and 93.3% (p<0.01) at 8 weeks.

The practical feasibility of the Carebee system with people with dementia, which was the objective of this study, was demonstrated, and it was clear that the system can be used adequately with light assistance.

No

https://jrct.mhlw.go.jp/latest-detail/jRCT1040240055

Yukihiko Washimi

National Center for Geriatrics and Gerontology

7-430 Morioka-cho Obu-shi Aichi, Japan

washimi@ncgg.go.jp

Maiko Asa

National Center for Geriatrics and Gerontology

7-430 Morioka-cho Obu-shi Aichi, Japan

+81-562-46-2311

crndinfo@ncgg.go.jp

Complete

April. 10, 2023

Interventional

single arm study

open(masking not used)

uncontrolled control

single assignment

health services research

Persons with dementia (the person in question)
1) Age: 65 years old or older and less than 95 years old (at the time of obtaining consent). The age of the caregiver is not required.
2) Medical examination category: Outpatients. Patients must have been diagnosed with dementia while attending the outpatient clinic of the National Institute for Longevity Sciences. The type of dementia does not matter.
3) Must be accompanied by a reliable caregiver for the duration of the study and must give written consent (a reliable caregiver must be physically and mentally healthy, have contact with the subject for at least one hour per week, and be able to participate in all interventions until the end of the study).
4) MMSE of at least 11 points within 6 months prior to consent.
5)Patients who have given their written consent to participate in the study.
6)The line condition must be 1.7 Gbps to 1 Gbps maximum transmission speed at the time of reception.

Caregivers
1) Any age.
2)Must be physically and mentally healthy, have contact with the subject for at least one hour per week, and be able to participate in all interventions until the end of the study by the same person.
3) Written consent to participate in the study must be obtained from the caregiver.

1) Has severe hearing impairment, dysarthria, or aphasia.
2) Patients who are inconvenienced by the communication status of their smartphones in their home environment.
3) Other patients who are deemed inappropriate by the principal investigator and the subinvestigator.

Both

dementia

Step 1: A Hubbit employee visits the home of the person with dementia who has a caregiver to install, set up, and explain the Carebee terminal to the person and caregiver. One week after the installation of the device and four weeks after the installation of the device, the attending physician conducts a 10-15 minute remote consultation with the person and caregiver using this system.
Step 2: After the 4-week consultation in Step 1, the Carebee Supporter explains how to use the Carebee terminal to the patient only. 1 week and 4 weeks after the start of Step 2 (8 weeks in total), the attending physician conducts a remote consultation.

D003704

Percentage of continued use of the system during the first 4 weeks of intervention.

1) Percentage of continued use of the system at 8 weeks after the start of the intervention.
2) Time (minutes) assisted to start using the system after 4 weeks of intervention.

+81-562-46-2311

April. 10, 2023

none